This topic contains a solution. Click here to go to the answer

Author Question: What is the evidence for and against viewing borderline personality disorder (BPD) as a distinct ... (Read 48 times)

erika

  • Hero Member
  • *****
  • Posts: 522
What is the evidence for and against viewing borderline personality disorder (BPD) as a distinct disorder?
 
  What will be an ideal response?

Question 2

What are the similarities and differences between schizoid personality disorder and schizotypal personality disorder?
 
  What will be an ideal response?



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

xiazhe

  • Sr. Member
  • ****
  • Posts: 331
Answer to Question 1

The idea that borderline personality disorder is distinct is based in part on evidence that it breeds true--relatives of those with borderline personality disorder are more likely to share this diagnosis than are family members of those with other personality disorders. Also, people with borderline personality disorder tend to keep the diagnosis throughout life, without developing a different or more serious condition such as schizophrenia. However, there is also evidence suggesting that borderline personality disorder is not distinct. About half of those with BPD also have a mood disorder, along with a family history of mood disorder. Diagnostic reliability is low because the characteristics of BPD overlap with other personality disorders. For example, some researchers have been unable to distinguish borderline personality disorder from histrionic personality disorder and antisocial personality disorder.

Answer to Question 2

Both are characterized by shallow emotions, few close relationships, and poor social skills. Schizotypal behavior is also characterized by perceptual and cognitive peculiarities and oddities of speech.





 

Did you know?

Russia has the highest death rate from cardiovascular disease followed by the Ukraine, Romania, Hungary, and Poland.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

Disorders that may affect pharmacodynamics include genetic mutations, malnutrition, thyrotoxicosis, myasthenia gravis, Parkinson's disease, and certain forms of insulin-resistant diabetes mellitus.

Did you know?

Excessive alcohol use costs the country approximately $235 billion every year.

Did you know?

Most strokes are caused when blood clots move to a blood vessel in the brain and block blood flow to that area. Thrombolytic therapy can be used to dissolve the clot quickly. If given within 3 hours of the first stroke symptoms, this therapy can help limit stroke damage and disability.

For a complete list of videos, visit our video library